Idaho Society of Clinical Oncology Starts First Statewide Personalized Medicine Tumor Board

    BOISE, ID, February 09, 2015 /24-7PressRelease/ -- Idaho Society of Clinical Oncology (ISCO) began its monthly statewide virtual personalized tumor board on February 2, 2015. The personalized medicine multidisciplinary tumor board was created to promote and foster the exchange of ideas among healthcare professionals in order to improve treatment planning for difficult cancer cases.

Tumor board is a patient care conference attended by physicians from different specialties. Dr. Binay Shah, ISCO President, presented on a patient with advanced lung cancer. Physicians and pharmacists from three cancer centers in Idaho attended the meeting and discussed management of the patient. "In the era of patient-centric care, we believe that our monthly statewide personalized medicine tumor board will help improve patient care in Idaho," said ISCO president Binay Shah MD.

Idaho Society of Clinical Oncology (ISCO) is a 501c(6) non-profit organization and a state affiliate of American Society of Clinical Oncology, the largest organization of clinical oncologists with more than 30000 members. ISCO is devoted to the improvement of hematologic and oncologic care of patients. For more information, visit www.idsco.org.

For more information, or to schedule an interview with any of our board members, please contact Mary Jo Richards at [email protected] or (918) 261-8951.

ISCO is a collective network of medical, surgical and radiation oncologists, hematologists, physician assistants, nurse practitioners, oncology nurses, practice partners, business administrators, and business staff.

# # #